Comment: there was some downsides

(See in situ)

In reply to comment: Now I remember... (see in situ)

there was some downsides

to the dosages in its original use to treat congenital metabolic diseases in children when it was first getting used, but the whole idea of kick starting the mitochondrial apoptosis pathways in cancerous cells by force them to start using oxidation phosphorylation again makes a lot of sense. Maybe DCA won't prove to be very good in the long run, but this kind of approach needs to be explored.